美股市場個股詳情

TEVJF TEVA PHARMACEUTICAL INDUSTRIES

添加自選
  • 22.750
  • 0.0000.00%
延時15分鐘行情收盤價 12/17 16:00 (美東)
257.77億總市值-26.76市盈率TTM

關於TEVA PHARMACEUTICAL INDUSTRIES公司

梯瓦製藥工業有限公司從事藥品的開發、生產和銷售。它通過以下地理部分運作:北美,歐洲和國際市場。

公司介紹

公司代碼TEVJF
公司名稱TEVA PHARMACEUTICAL INDUSTRIES
上市日期2012/05/30
成立日期1901
CEOMr. Richard D. Francis
所屬市場粉單
員工數量37851
年結日12-31
公司地址124 Dvora HaNevi'a Street
城市特拉維夫
省份特拉維夫
國家以色列
郵編6944020
電話972-3-914-8213

董事高管

  • 姓名
  • 職務
  • 年薪
  • Richard D. Francis
  • Director, President and Chief Executive Officer
  • 2570.69萬
  • David R. McAvoy
  • Executive Vice President and Chief Legal Officer
  • --
  • Eli Kalif
  • Executive Vice President and Chief Financial Officer
  • 494.38萬
  • Amir Weiss
  • Senior Vice President and Chief Accounting Officer
  • --
  • Eric A Hughes
  • Executive Vice President, Global R&D and Chief Medical Officer
  • --
  • Mark Sabag
  • Executive Vice President, International Markets Commercial
  • 372.91萬
  • Richard Daniell
  • Executive Vice President, European Commercial
  • 516.42萬
  • Matthew Shields
  • Executive Vice President, Global Operations
  • --
  • Angus Grant
  • Executive Vice President, Business Development
  • --
  • Christine Fox
  • Executive Vice President, U.S. Commercial
  • --
  • Dr. Sol J. Barer,PhD
  • Chairman of the Board
  • 54.00萬
  • Gerald M. Lieberman
  • Independent Director
  • 35.50萬
  • Janet S. Vergis
  • Independent Director
  • 32.55萬
  • Chen Lichtenstein
  • Independent Director
  • --
  • Amir Elstein
  • Independent Director
  • 34.00萬
  • Professor Ronit Satchi-Fainaro
  • Independent Director
  • 31.52萬
  • Professor Varda Shalev
  • Independent Director
  • 17.67萬
  • Dr. Tal Zaks, M.D.,PhD
  • Independent Director
  • 33.00萬
  • Dr. Perry D. Nisen
  • Independent Director
  • 32.79萬
  • Roberto A. Mignone
  • Independent Director
  • 34.00萬
  • Rosemary A. Crane, M.B.A.
  • Independent Director
  • 33.00萬
  • Vikki L. Conway
  • Acting Head of Global Human Resources
  • --
美股市場投資機會
成長股 成長股

成长股策略挑选具有卓越增长表现的企业。聚焦流通市值≥5亿美元、净利润增长率年报≥15%、毛利率≥50%、净资产收益率年报≥15%且ROE同比增长率>50%的股票,旨在寻找财务状况强劲且成长性极高的公司。 成长股策略挑选具有卓越增长表现的企业。聚焦流通市值≥5亿美元、净利润增长率年报≥15%、毛利率≥50%、净资产收益率年报≥15%且ROE同比增长率>50%的股票,旨在寻找财务状况强劲且成长性极高的公司。